Third Wave also announced that four well-known regional distributors have been secured to distribute its human papillomavirus (HPV) product in Italy. The company recently announced that its HPV high-risk screening test has achieved European CE Marking certification. The test is used in the routine screening of women for cervical cancer.
Kevin Conroy, president and CEO of Third Wave, said: “Third Wave has taken another significant step forward in our HPV commercialization plans with the appointment of our first European HPV test distributors. Inverness Medical Iberica provides Third Wave with a well-established, substantial sales force in Spain and Portugal, both key countries driving HPV testing growth in Europe. We look forward to bringing our HPV high-risk screening test to market in those countries through Inverness Medical this year.”